BioSig Technologies, OTC Stock Executives
| BSGM Stock | USD 0.49 0.06 10.91% |
BioSig Technologies, employs about 4 people. The company is managed by 11 executives with a total tenure of roughly 10 years, averaging almost 0.0 years of service per executive, having 0.36 employees per reported executive. Analysis of BioSig Technologies,'s management performance can provide insight into the firm performance.
| Kenneth MBA CEO CEO Founder |
| Frederick Hrkac President Executive President |
BioSig |
BioSig Technologies, Management Team Effectiveness
The company has return on total asset (ROA) of (4.478) % which means that it has lost $4.478 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (59.7735) %, meaning that it created substantial loss on money invested by shareholders. BioSig Technologies,'s management efficiency ratios could be used to measure how well BioSig Technologies, manages its routine affairs as well as how well it operates its assets and liabilities.BioSig Technologies, Workforce Comparison
BioSig Technologies, Common is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,229. BioSig Technologies, adds roughly 4.0 in number of employees claiming only tiny portion of equities under Health Care industry.
BioSig Technologies, Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioSig Technologies, insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioSig Technologies,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BioSig Technologies, insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BioSig Technologies, Notable Stakeholders
A BioSig Technologies, stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioSig Technologies, often face trade-offs trying to please all of them. BioSig Technologies,'s stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioSig Technologies,'s stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kenneth MBA | CEO Founder | Profile | |
| Frederick Hrkac | Executive President | Profile | |
| Steven CPA | Chief Officer | Profile | |
| John Sieckhaus | Chief Officer | Profile | |
| Budimir Drakulic | Chief Scientist | Profile | |
| Steven Buhaly | Chief Officer | Profile | |
| Gray Fleming | Chief Officer | Profile | |
| Andrew Ballou | Vice Relations | Profile | |
| MBA MBA | CEO Founder | Profile | |
| Brenda Castrodad | VP HR | Profile | |
| Michael Fleming | Chief Officer | Profile |
About BioSig Technologies, Management Performance
The success or failure of an entity such as BioSig Technologies, often depends on how effective the management is. BioSig Technologies, management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioSig management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioSig management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.
The data published in BioSig Technologies,'s official financial statements typically reflect BioSig Technologies,'s business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving BioSig Technologies,'s quantitative information. For example, before you start analyzing numbers published by BioSig accountants, it's essential to understand BioSig Technologies,'s liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.
BioSig Technologies, Workforce Analysis
Traditionally, organizations such as BioSig Technologies, use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioSig Technologies, within its industry.BioSig Technologies, Manpower Efficiency
Return on BioSig Technologies, Manpower
| Revenue Per Employee | 4.5K | |
| Revenue Per Executive | 1.6K | |
| Net Loss Per Employee | 7.2M | |
| Net Loss Per Executive | 2.6M |
Other Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.